377 related articles for article (PubMed ID: 16675962)
1. Peroxisome proliferator-activated receptors increase human sebum production.
Trivedi NR; Cong Z; Nelson AM; Albert AJ; Rosamilia LL; Sivarajah S; Gilliland KL; Liu W; Mauger DT; Gabbay RA; Thiboutot DM
J Invest Dermatol; 2006 Sep; 126(9):2002-9. PubMed ID: 16675962
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes.
Mastrofrancesco A; Ottaviani M; Cardinali G; Flori E; Briganti S; Ludovici M; Zouboulis CC; Lora V; Camera E; Picardo M
Biochem Pharmacol; 2017 Aug; 138():96-106. PubMed ID: 28461124
[TBL] [Abstract][Full Text] [Related]
3. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
4. Adapalene suppresses sebum accumulation via the inhibition of triacylglycerol biosynthesis and perilipin expression in differentiated hamster sebocytes in vitro.
Sato T; Akimoto N; Kitamura K; Kurihara H; Hayashi N; Ito A
J Dermatol Sci; 2013 Jun; 70(3):204-10. PubMed ID: 23473858
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
Schuster M; Zouboulis CC; Ochsendorf F; Müller J; Thaçi D; Bernd A; Kaufmann R; Kippenberger S
Br J Dermatol; 2011 Jan; 164(1):182-6. PubMed ID: 21091942
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.
Strakova N; Ehrmann J; Bartos J; Malikova J; Dolezel J; Kolar Z
Neoplasma; 2005; 52(2):126-36. PubMed ID: 15800711
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of imperatorin on insulin-like growth factor-1-induced sebum production in human sebocytes cultured in vitro.
Hwang YL; Im M; Lee MH; Roh SS; Choi BW; Kim SJ; Sohn KC; Lee Y; Seo YJ; Lee JH; Kim CD
Life Sci; 2016 Jan; 144():49-53. PubMed ID: 26631504
[TBL] [Abstract][Full Text] [Related]
10. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
Patel JJ; Butters OR; Arnett TR
Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
[TBL] [Abstract][Full Text] [Related]
11. Expression of steroidogenic enzymes in human sebaceous glands.
Inoue T; Miki Y; Kakuo S; Hachiya A; Kitahara T; Aiba S; Zouboulis CC; Sasano H
J Endocrinol; 2014 Sep; 222(3):301-12. PubMed ID: 24938708
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
13. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
[TBL] [Abstract][Full Text] [Related]
14. Acne and sebaceous gland function.
Zouboulis CC
Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
[TBL] [Abstract][Full Text] [Related]
15. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
16. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.
Ribet C; Montastier E; Valle C; Bezaire V; Mazzucotelli A; Mairal A; Viguerie N; Langin D
Endocrinology; 2010 Jan; 151(1):123-33. PubMed ID: 19887568
[TBL] [Abstract][Full Text] [Related]
18. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
Huang TH; Roufogalis BD
Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
[TBL] [Abstract][Full Text] [Related]
19. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Koufany M; Jouzeau JY; Moulin D
Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
